Chiang Pei-Chi, Chou Ruey-Hwang, Chien Hsiung-Fei, Tsai Tsuimin, Chen Chin-Tin
Department of Biochemical Science and Technology, National Taiwan University, Taipei 10617, Taiwan.
Lasers Surg Med. 2013 Jan;45(1):38-47. doi: 10.1002/lsm.22112. Epub 2013 Jan 15.
The mechanisms of photodynamic therapy (PDT) have been studied on the cellular and tissue levels. However, the cellular behaviors of cancer cells survived from PDT are still not clear. Previously, we have found that PDT-derived variants A375/3A5 and A375/6A5 have reduced invasion ability. This study attempted to further elucidate the possible molecules associated with the altered invasiveness in the PDT-derived variants and cancer cells treated with PDT.
STUDY DESIGN/MATERIALS AND METHODS: Scratch wound healing assay and invasion assay were performed to evaluate the migration and invasion ability of human A375 melanoma and MDA-MB-231 breast adenocarcinoma cells. Single colony selection and microarray analysis were performed to examine the differentially expressed transcripts in parental A375 and PDT-derived variants. RT-PCR and Western blots analysis were performed to examine the expression levels of matrix metalloproteinase 9 (MMP9) and chloride intracellular channel 4 (CLIC4). The MMP9 activity was examined by Zymography assay. CLIC4 expressing construct was used to examine the influence on MMP9 expression and invasion ability of cancer cells treated with PDT.
Correlated with the reduced invasiveness, we found that A375/3A5 and A375/6A5 cells have decreased production of MMP9. Microarray analysis and RT-PCR showed CLIC4 was down-regulated in the PDT-derived variants. Furthermore, down-regulation of CLIC4 and MMP9 was found in cancer cells treated with PDT. Transfection of surviving cancer cells with a plasmid vector encoding CLIC4 increased MMP9 expression and cell invasion. Furthermore, overexpression of CLIC4 in A375 and MDA-MB-231 cancer cells constrains PDT-induced suppression of invasiveness.
Our results showed that the reduced expression of CLIC4 could further down-regulate MMP9 and result in the suppression of invasion in cancer cells treated with PDT. These results provide an insight into a new mechanism by which PDT affects the metastatic potential of cancer cells through down-regulation of MMP9 by CLIC4.
光动力疗法(PDT)的作用机制已在细胞和组织水平上进行了研究。然而,经PDT处理后存活的癌细胞的细胞行为仍不清楚。此前,我们发现PDT衍生变体A375/3A5和A375/6A5的侵袭能力降低。本研究试图进一步阐明与PDT衍生变体及经PDT处理的癌细胞侵袭性改变相关的可能分子。
研究设计/材料与方法:进行划痕伤口愈合试验和侵袭试验,以评估人A375黑色素瘤细胞和MDA-MB-231乳腺腺癌细胞的迁移和侵袭能力。进行单克隆选择和微阵列分析,以检测亲本A375细胞和PDT衍生变体中差异表达的转录本。进行逆转录聚合酶链反应(RT-PCR)和蛋白质免疫印迹分析,以检测基质金属蛋白酶9(MMP9)和氯离子细胞内通道4(CLIC4)的表达水平。通过酶谱分析检测MMP9活性。使用CLIC4表达构建体来检测其对经PDT处理的癌细胞的MMP9表达和侵袭能力的影响。
与侵袭性降低相关,我们发现A375/3A5和A375/6A5细胞中MMP9的产生减少。微阵列分析和RT-PCR显示CLIC4在PDT衍生变体中表达下调。此外,在经PDT处理的癌细胞中也发现CLIC4和MMP9表达下调。用编码CLIC4的质粒载体转染存活的癌细胞可增加MMP9表达和细胞侵袭。此外,在A375和MDA-MB-231癌细胞中过表达CLIC4可抑制PDT诱导的侵袭性抑制。
我们的结果表明,CLIC4表达降低可进一步下调MMP9,并导致经PDT处理的癌细胞侵袭受到抑制。这些结果为PDT通过CLIC4下调MMP9影响癌细胞转移潜能的新机制提供了见解。